Humacyte (HUMA) Interest Coverage Ratio (2020 - 2026)
Humacyte (HUMA) posted quarterly Interest Coverage Ratio of 12.73 for Q1 2026, down 64.56% year-over-year from 35.9 in Q1 2025, and up 75.82% quarter-over-quarter from 52.62 in Q4 2025.
Humacyte (HUMA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Interest Coverage Ratio for 7 consecutive years, with 12.73 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 64.56% year-over-year to 12.73; the TTM figure through Mar 2026 stood at 13.55 (down 22.7% YoY), while the FY2025 annual figure was 9.61, down 1436.52% from the prior year.
- Interest Coverage Ratio rose to 12.73 in Q1 2026 per HUMA's latest filing, from 52.62 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.39 in Q3 2025 and bottomed at 52.62 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 13.55 across 5 years, with a median of 12.69 in 2022.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 1761.13% — and 2025, when it jumped 96.84%.
- Humacyte's Interest Coverage Ratio stood at 12.69 in 2022, then soared by 58.7% to 5.24 in 2023, then tumbled by 155.17% to 13.38 in 2024, then slumped by 293.43% to 52.62 in 2025, then jumped by 75.82% to 12.73 in 2026.
- Business Quant data shows HUMA's Interest Coverage Ratio at 12.73 in Q1 2026, 52.62 in Q4 2025, and 0.39 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Humacyte | 158.12 Mn | 158.12 Mn | -825,000.00 | -11.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.63 |
| Mar 31, 2026 | -12.73 |
| Dec 31, 2025 | -52.62 |
| Sep 30, 2025 | -0.39 |
| Jun 30, 2025 | -11.68 |
| Mar 31, 2025 | -7.73 |
| Dec 31, 2024 | -13.38 |
| Sep 30, 2024 | -12.40 |
| Jun 30, 2024 | -11.73 |
| Mar 31, 2024 | -14.65 |
| Dec 31, 2023 | -5.24 |
| Sep 30, 2023 | -16.83 |
| Jun 30, 2023 | -15.63 |
| Mar 31, 2023 | -13.24 |
| Dec 31, 2022 | -12.69 |
| Sep 30, 2022 | -14.32 |
| Jun 30, 2022 | -12.45 |
| Mar 31, 2022 | -2.72 |
| Dec 31, 2021 | -15.49 |
| Sep 30, 2021 | -0.77 |